Dihydropyridine Calcium Antagonists: Beneficial or Adverse Effects in the Setting of Myocardial Ischaemia/Reperfusion?

Abstract

Dihydropyridine (DHP) calcium antagonists are established drugs in the management of hypertension and chronic stable angina. However, recently a dose-related increase in the mortality of patients with coronary artery disease with nifedipine has been suggested. The conclusions of this study were seriously contradicted. Therefore, in our laboratory, the effect of the DHP calcium antagonist nisoldipine on ischaemic myocardial blood flow and function, infarct size, and the functional recovery of reversibly injured, reperfused myocardium was once more investigated in controlled in vivo models. In anaesthetized dogs, in the presence of a severe coronary artery stenosis, intravenous nisoldipine decreased poststenotic subendocardial blood flow and contractile function when arterial pressure was decreased. In contrast, when hypotension was prevented by inflation of an intra-aortic balloon, no aggravation of myocardial ischaemia was seen. During exercise, when aortic pressure is raised by catecholamines, nisoldipine may therefore not exert a proischaemic effect, but may rather improve regional myocardial blood flow and function in the ischaemic region. As has been shown for nifedipine, the functional antagonism of α-adrenergic coronary vasomotor tone contributes to the improvement of myocardial blood flow and function of the ischaemic region, in particular during exercise. In anaesthetized pigs, intracoronary administration of nisoldipine prior to a 90-min low-flow ischaemia tended to decrease infarct size. Infarct size resulting from prolonged and severe myocardial ischaemia is reduced by one or more preceding short episodes of ischaemia and reperfusion, a phenomenon called ischaemic preconditioning. A transient exposure to exogenous calcium has been shown to mimic ischaemic preconditioning. Thus, a blockade of calcium channels may interfere with this reduction of infarct size. However, in anaesthetized pigs, nisoldipine did not prevent the reduction of infarct size by ischaemic preconditioning. Reperfused myocardium after short periods of myocardial ischaemia is characterized by a reversible, prolonged depression of myocardial function, a phenomenon called myocardial stunning. In anaesthetized dogs, preischaemic intravenous administration of nisoldipine improved the functional recovery of stunned myocardium following a 15-min complete occlusion of the left circumflex coronary artery. Since myocardial blood flow during myocardial ischaemia and reperfusion was not altered and afterload was kept constant by an intra-aortic balloon, the beneficial effect of nisoldipine appears to be related to an attenuated calcium overload during early myocardial ischaemia. In conclusion, proischaemic effects of calcium antagonists can be avoided when the dosage or mode of administration are adjusted to prevent significant decreases in arterial pressure. Patients in such a way under treatment with calcium antagonists will experience an increase in exercise tolerance and also a better recovery of contractile function after the termination of...

Nitroprusside Attenuates Myocardial Stunning Through Reduced Contractile Delay and Time

“…Both L‐type calcium channel blockers and agents that increase local adenosine levels have been claimed to have beneficial effects on myocardial stunning (9, 28–30). Some evidence has suggested that this protection might be related to reduced calcium levels.…”

The Effects of Medications on Myocardial Perfusion

“…In a canine model of severe coronary artery stenosis, nifedipine increased coronary flow in areas of ischemia by combating the antagonism of alpha-adrenergic coronary vasomotor tone during exercise (68). Another large experimental model demonstrated that pre-treatment with verapamil reduced the size of subendocardial infarcts in the ischemic territory and preserved regional function (64,68). Clinical studies.…”

Study of the possible medical and medication explanatory factors of angiographic outcomes in patients with acute ST elevation myocardial infarction undergoing primary percutaneous intervention

“…[11] A large scale experimental study demonstrated that pre-treatment with verapamil can reduce the ischemic size of subendocardial infarcts and can preserve the function of ischemic region. [1213] Interestingly, it has been shown that calcium-channel blockers have inhibitory effects on platelet aggregation and thrombus formation, which may improve myocardial perfusion. [1415] Demir et al .…”